Abivax (AAVXF) Shares Outstanding (Diluted) (2021 - 2026)
Powered by 
Analysis
Abivax (AAVXF) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.20 Bn | 198.21 Bn | 7.24 Bn | 544.00 Mn |
| 2 | Gilead Sciences | 181.83 Bn | 178.65 Bn | 6.22 Bn | 1.24 Bn |
| 3 | Vertex Pharmaceuticals | 132.47 Bn | 124.61 Bn | 2.84 Bn | 255.20 Mn |
| 4 | Regeneron Pharmaceuticals | 82.56 Bn | 74.56 Bn | 3.93 Bn | 106.00 Mn |
| 5 | Argenx Se | 61.59 Bn | 56.40 Bn | 1.37 Bn | 66.03 Mn |
| 6 | Moderna | 54.65 Bn | 49.51 Bn | 52.00 Mn | 398.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.13 Bn | 30.82 Bn | 992.69 Mn | 138.28 Mn |
| 8 | Biogen | 31.42 Bn | 30.13 Bn | 1.96 Bn | 148.70 Mn |
| 9 | Roivant Sciences | 30.21 Bn | 30.21 Bn | 1.16 Mn | 720.78 Mn |
| 10 | Abivax | 10.92 Bn | 10.92 Bn | - | 69.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 69.53 Mn |
| Dec 31, 2025 | 69.53 Mn |
| Sep 30, 2025 | 63.05 Mn |
| Jun 30, 2025 | 63.05 Mn |
| Mar 31, 2025 | 63.05 Mn |
| Dec 31, 2024 | 63.05 Mn |
| Sep 30, 2024 | 43.07 Mn |
| Jun 30, 2024 | 43.07 Mn |
| Mar 31, 2024 | 43.07 Mn |
| Dec 31, 2023 | 43.07 Mn |
| Dec 31, 2022 | 19.09 Mn |
| Dec 31, 2021 | 15.46 Mn |